Cell Signaling Technology (CST)
Developing quality research antibodies
- B2B
About Cell Signaling Technology (CST)
A privately-owned research institute specializing in developing high-quality antibodies for cancer research, validated by PhD scientists for reliable results
Key facts
- Industry
- Biotechnology Research
- Company size
- 1,001–5,000 employees
- Headquarters
- Danvers, Massachusetts, United States
- Founded
- 1999
- Revenue
- $53.3M – $421MTamtam estimate
- Website
- cellsignal.com
Cell Signaling Technology (CST) at a glance
Cell Signaling Technology (CST) is a B2B company in the Biotechnology Research industry, headquartered in Danvers, Massachusetts, United States.
Cell Signaling Technology (CST) was founded in 1999.
Cell Signaling Technology (CST) has 1,001–5,000 employees.
Cell Signaling Technology (CST)'s revenue is $53.3M – $421M (Tamtam estimate).
Frequently asked questions about Cell Signaling Technology (CST)
What is Cell Signaling Technology (CST)'s revenue?
Tamtam estimates Cell Signaling Technology (CST)'s annual revenue at $53.3M – $421M.
How many employees does Cell Signaling Technology (CST) have?
Cell Signaling Technology (CST) has 1,001–5,000 employees.
Where is Cell Signaling Technology (CST) headquartered?
Cell Signaling Technology (CST) is headquartered in Danvers, Massachusetts, United States.
Selling to companies like Cell Signaling Technology (CST)?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies